In vitro effects of the platelet glycoprotein IIb/IIIa receptor antagonists c7E3 fab on the activated clotting time - Response

被引：0
|
作者：
Amar, T
Coller, BS
机构：
来源：
CIRCULATION | 1997年 / 96卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3794 / 3794
页数：1
相关论文
共 50 条
  • [31] Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa (αIIb/β3) receptor-directed platelet inhibition
    Li, YF
    Spencer, FA
    Becker, RC
    AMERICAN HEART JOURNAL, 2001, 142 (02) : 204 - 210
  • [32] Labeling of the internal pool of GP IIb-IIIa in platelets by c7E3 Fab fragments (abciximab):: Flow and endocytic mechanisms contribute to the transport
    Nurden, P
    Poujol, C
    Durrieu-Jais, C
    Winckler, J
    Combrié, R
    Macchi, L
    Bihour, C
    Wagner, C
    Jordan, R
    Nurden, AT
    BLOOD, 1999, 93 (05) : 1622 - 1633
  • [33] SONOCLOT CAN SIMULTANEOUSLY MONITOR GLYCOPROTEIN IIB/IIIA-MEDIATED PLATELET INHIBITION, ACTIVATED CLOTTING TIME AND CLOT RATE RESULTS
    Barnes, C.
    Baird, C. H.
    Pisani, C.
    Henderson, J.
    Wischmeyer, P.
    SHOCK, 2016, 45 (06): : 87 - 88
  • [34] Effects of glycoprotein IIb/IIIa antagonists on platelet activation: development of a transfer method to mimic peak to trough receptor occupancy
    Billheimer, JT
    He, BK
    Spitz, SM
    Stern, AM
    Seiffert, D
    THROMBOSIS RESEARCH, 2002, 107 (06) : 303 - 317
  • [35] STRIKING CLINICAL BENEFIT WITH PLATELET GP IIB/IIIA INHIBITION BY C7E3 AMONG PATIENTS WITH UNSTABLE ANGINA - OUTCOME IN THE EPIC TRIAL
    LINCOFF, AM
    CALIFF, RM
    ANDERSON, K
    WEISMAN, HF
    TOPOL, EJ
    CIRCULATION, 1994, 90 (04) : 21 - 21
  • [36] Dose dependent effects of c7E3 Fab on modified thromboelastography in healthy volunteers
    Greilich, PE
    Carr, ME
    Cooley, MV
    Harris, DN
    Carr, SL
    Whitten, CW
    ANESTHESIA AND ANALGESIA, 1998, 86 (2S):
  • [37] Dissociation between the anti-aggregatory & anti-secretory effects of platelet integrin αIIbβ3 (GPIIb/IIIa) antagonists, c7E3 and DMP728 (vol 88, pg 137, 1997)
    Tsao, PW
    Forsythe, MS
    Mousa, SA
    THROMBOSIS RESEARCH, 1998, 89 (02) : 97 - 97
  • [38] XV454, a novel nonpeptide small-molecule platelet GIIb/IIIa antagonist with comparable platelet αIIbβ3-binding kinetics to c7E3
    Mousa, SA
    Forsythe, M
    Bozarth, J
    Youssef, A
    Wityak, J
    Olson, R
    Sielecki, T
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 32 (05) : 736 - 744
  • [39] THE EFFECT OF THROMBIN RECEPTOR ACTIVATING PEPTIDE ON PLATELET-AGGREGATION IN PATIENTS UNDERGOING GLYCOPROTEIN IIB/IIIA RECEPTOR BLOCKADE WITH 7E3
    KLEIMAN, NS
    JORDAN, R
    COLLER, B
    NORTON, D
    WEISMAN, H
    MERCADO, C
    ROSE, D
    TRAINOR, K
    JOHNSON, S
    BUSCHMANN, L
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, : A63 - A63
  • [40] MONITORING THE ANTIPLATELET EFFECTS OF C7E3 FAB (REOPRO(TM)) IN HEPARINIZED SURGICAL PATIENTS
    GREILICH, P
    ALVING, B
    HEALEY, P
    CHANG, A
    ONEILL, K
    REID, T
    ANESTHESIOLOGY, 1995, 83 (3A) : A98 - A98
12345